Home›Companies›Biotech & Pharma›Entact Bio

Entact Bio, Inc.

Develops medicines that enhance protein function for people with diseases.

Updated Nov 10, 2026·Latest SEC filing Jun 3, 2026·Suggest an edit

About Entact Bio

Entact Bio is a private company based in Watertown, Massachusetts, incorporated in 2021 in Delaware. It has reported $50,321,697 raised in two offerings on Form D since January 2024. Its chief executive is Victoria Richon.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jan 8, 2026Jun 3, 2026$9,999,997fully sold7$1.4MEquityRule 506(b)Form D ↗
Jan 19, 2024Jan 31, 2024amended May 15, 2024$40,321,700fully sold7$5.7MEquityRule 506(b)Form D/A ↗1 earlier filing
Total, two offerings$50,321,697

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Entact Bio's Form D filed Jun 3, 2026.

AS
Pini Orbach
Pini Orbach
Director
Also a director at Auron Therapeutics.
Victoria Richon
Victoria Richon
CEO, Board Member
Also a director at Auron Therapeutics.
OS
Owen Smith
Board Member
Also a director at Estuary Bio.

Earlier filings also listed Alon Lazarus (director, last listed May 2024).

Sources

  1. SECEntact Bio, Inc. Form D, filed Jan 31, 2024
  2. SECEntact Bio, Inc. filing history
  3. CompanyContact
  4. CompanyPrivacy policy and terms of service